000 01343 a2200313 4500
005 20250517204909.0
264 0 _c20181105
008 201811s 0 0 eng d
022 _a1469-0691
024 7 _a10.1016/j.cmi.2018.02.031
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMikulska, M
245 0 0 _aFluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?
_h[electronic resource]
260 _bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_cJul 2018
300 _a678-679 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAntibiotic Prophylaxis
650 0 4 _aDisease Management
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aFluoroquinolones
_xtherapeutic use
650 0 4 _aHematologic Neoplasms
_xcomplications
650 0 4 _aHumans
650 0 4 _aNeutropenia
_xcomplications
650 0 4 _aOpportunistic Infections
_xetiology
650 0 4 _aOutcome Assessment, Health Care
700 1 _aCordonnier, C
773 0 _tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_gvol. 24
_gno. 7
_gp. 678-679
856 4 0 _uhttps://doi.org/10.1016/j.cmi.2018.02.031
_zAvailable from publisher's website
999 _c28188630
_d28188630